tion, loss of kidney function and end-stage kidney disease) for AKI definition were identified and successively revised [1, 3] : the application of these classifications to clinical practice showed how the acknowledgment of different levels of renal dysfunction can effectively identify clinical risk factors and eventually improve therapy and prevention [4] . Two most important clinical trials on the dose and prescription of renal replacement therapy (RRT) either in intermittent (Acute Renal Failure Trial Network, ATN) or continuous therapies (ATN and the Randomized Evaluation of Normal versus Augmented Level, RE-NAL) definitely established the adequate level of dialysis to be recommended in critically ill patients [5, 6] . Recently, two important large surveys [the Dose Response Multicentre International collaborative Initiative (DoReMi) and the Beginning and Ending Supportive Therapy for the Kidney (BEST)] provided insightful information on AKI epidemiology, classification and therapy, RRT prescription delivery, timing, cost and mortality [7] [8] [9] [10] [11] [12] . Nevertheless, the clinical practice of AKI management still shows a significant level of uncertainty and a lack of standard among many clinicians and operators. Following an observational practice-related approach, we asked the participants of an international course on critical care nephrology specific questions about practice patterns in AKI classification and therapy in order to verify whether routine clinical practice actually presents significant differences from what has been reported in the available literature.
Subjects and Methods
A questionnaire was widely distributed during the meeting and participants were invited to voluntarily complete the survey. Responses from participants who attended the Fourth Critical Care Nephrology International Survey held in Vicenza, Italy were surveyed. The questionnaire was a slightly modified version of the format used at the same meeting held 3 years previously [13] . Questionnaires were anonymous and completing them was not obligatory: participants were asked to share their individual experience and/or opinions. The form included 4 demographic questions and 17 multiple-choice questions and was divided into three sections. (1) The first section sought information about the participants' background and working environment. (2) The second section examined the definition of AKI and when the initiating of RRT was clinically indicated. (3) The third section looked at the availability of technology in different hospitals and sought the participants' views about different technical aspects of RRT (techniques and modality of RRT, type of anticoagulation, machines available for therapy) and explored specific questions about RRT management (RRT protocols, dose prescription, complications of RRT).
Statistical Analysis
All documents were analyzed with reference to a Microsoft Access database, which an independent pool of researchers had compiled from hardcopy sources. All data are presented either as absolute numbers or as a percentage of the examined questionnaires (n = 440). Statistical analysis was performed using the SPSS 11.5 software package. The 2 test was used to compare proportions. p ! 0.05 was considered statistically significant.
Results

Section 1
Four hundred and sixty questionnaires were collected from 607 participants; of these, 440 (96%) had been correctly completed and were therefore considered for the present analysis. Sixteen forms were excluded from analysis because more than 30% of the questions had not been answered. It should be mentioned that Europe continued to dominate greatly (72%) but participation from the rest of the world (28%) had increased significantly ( fig. 1 ) compared to previous years [13, 14] and overall 5 continents and 58 nations were represented at the meeting. Specialties were quite evenly distributed, since 55% of responders were nephrologists and 45% intensivists. Academic and nonacademic centers participated in similar proportions: 56% of participants came from university hospitals or teaching hospitals, whereas 44% came from city or community hospitals. 
Section 2
Participants were asked to select one or more of four possible criteria to diagnose AKI: oligoanuria, increase in creatinine, decrease in urine output (UO) or RIFLE criteria. Interestingly, the most common answer was RIFLE criteria (55%) followed by the presence of oligoanuria (24%). Creatinine was selected by 10% of responders and 4% used the decrease in UO as a criterion ( fig. 2 ). The remainder (7%) selected a combination of the above answers giving 19 different definitions. The timing to start dialysis is an interesting and particularly complex topic: participants were asked to indicate which level of creatinine, diuresis, potassium and fluid overload triggered their decision to prescribe RRT in the ICU. Responders seemed to preferentially start dialysis within creatinine ranges of 2.3-3.4 mg/dl (28%) and 3.4-4.5 mg/dl (26%) and within blood urea nitrogen ranges of 29-67 mg/dl (14%) and 68-115 mg/dl (37%). Potassium levels to start extracorporeal treatment reached a high consensus around the range of 6-6.9 mmol/l (51%). The majority of our participants would start RRT with a UO level of 150-200 ml/12 h (43%) or 100-150 ml/12 h (18%). When fluid overload was analyzed, surprisingly, about 30% of responders indicated that they would prescribe dialysis only in case of severe fluid overload (requiring mechanical ventilation and/or causing impaired skin integrity), whereas another 25% would prescribe it in case of moderate to severe fluid overload and less than 20% of responders in case of mild to moderate fluid overload. Interestingly, 74% of answers to the question of indicating 'which of the above indications to begin RRT is the most common' remained blank, showing how the indication to start RRT is complex and often multifactorial. A wide agreement seemed to be present on the prescription of RRT for extended indications (i.e. sepsis), either isolated (54%) and with a simultaneous presence of AKI (63%).
Section 3
As far as the management of continuous RRT (CRRT) is concerned, 37% of responders admitted that there is no standardized protocol at their institution. Overall availability of techniques in different institutions was analyzed: absolute analysis of RRT techniques used showed that CRRT was preferred by most specialists (86%), followed by intermittent hemodialysis (65%) and sustained low-efficiency dialysis (28%). Notably, peritoneal dialysis was considered by 30% of responders. It is interesting to note that there was a significant difference between intensivists and nephrologists ( fig. 3 ): apparently, there is a similar preference for continuous techniques (CRRT) between the two groups, whereas the nephrologists tend to choose more frequently intermittent techniques (inter- Criteria used by participants to define AKI. Responders had the option to select more than one answer. mittent hemodialysis or sustained low-efficiency dialysis) and peritoneal dialysis (p ! 0.01). In particular, it was confirmed that the vast majority have different choices for the prescription of RRT at their disposal: in fact, only 34% of responders answered that they routinely use only one dialytic technique in their institution, whereas 31% have a choice between at least two techniques and 24% between three different dialytic techniques; apparently, 11% of our participants use all four forms of dialysis. Participants were then asked to specify their routinely used modality (or combinations of modalities) for blood purification. As depicted in figure 4 , hemofiltration (HF) and hemodiafiltration (HDF) were the prevalent options, selected in 69 and 48% of cases, while hemodialysis (39%) was the least frequent choice. Subgroup differences were significant (p ! 0.01), since intensivists apparently tended to preferentially prescribe HF and HDF, whereas the choice of nephrologists between HF, hemodialysis and HDF was more balanced. Unfractionated heparin (whether at high or low doses) remained the preferred anticoagulant choice, having been selected by more than 80% of participants. Low-molecular-weight heparins or infusion of citrate were both selected in about one fifth of cases.
The following question concerned the participants' view about the prescription of RRT dose. The most frequently selected dosage was 35 ml/kg/h (46%) ( fig. 5 ) . A relatively high number of blank answers (17%) and a large 
Discussion
We took advantage of an international meeting on CRRT and critical care nephrology (Third Critical Care Nephrology International Survey, held in Vicenza, Italy, in 2007) to investigate the clinicians' view about AKI management by means of a questionnaire. The group of participants was quite large (n = 444) and a broad distribution was evident. A significant improvement was shown regarding questions on the definition of AKI in comparison to 2004: the use of RIFLE significantly increased (from 16 to 55%) and the number of different combined definitions decreased accordingly (from about 200 to 19) [13] . In 2007, RIFLE criteria were chosen by the absolute majority of the participants and only few of them still required a personalized definition. This finding was not surprising in the light of increasing reports in the literature of the adult and pediatric patients critically ill with AKI. The indication to start RRT was more thoroughly investigated compared to previous surveys: our responders seem to prescribe dialysis relatively early, when low to medium levels of creatinine and urea are reached. What may look surprising, however, is the fact that very low levels of UO or severe fluid overload were preferentially selected as an indication for starting RRT: the great impact of fluid balance on the mortality of AKI patients might have been underestimated in the last years and it will probably be reevaluated in the near future in the light of recent observational papers [15, 16] . As far as nonrenal indications are concerned, 54% of responders stated that they (conceptually) agree with nonrenal indications. The lack of scientific evidence is usually the main reason for skepticism about adopting extracorporeal treatment; nonetheless, a fair amount of responders declared that they would start RRT in case of septic shock even in the absence of AKI. This contradiction was, however, less evident than in 2004, when about 90% of clinicians declared that they agreed with RRT for nonrenal indications. An analysis of techniques available in different institutions showed a certain prevalence of continuous techniques. Nevertheless, it was shown that different techniques were available in about 66% of institutions. As shown in our survey 4 years earlier, a large number of the participants seemed uncertain about prescribed treatments: participants usually claimed that they prescribe a dose of 35 ml/kg/h (46%) but more than one third of those that responded did not provide an explicit answer to this question. It must be said, however, that the number of unclear responses to this question was significantly higher in 2004 (54% of questions unanswered) and the dose of 35 ml/kg/h was then selected by only 25% of people [13] . As a matter of fact, unfractionated heparin infusion was still the preferred anticoagulation technique, followed by low-molecular-weight heparin and citrate. Anticoagulation side effects (bleeding and filter clotting) are still a cause for complaint. Interestingly, the other technical and clinical issues and complaints which occur during RRT still seem to be similar to those in 2004, maybe showing that there has been little improvement in the technical aspects of RRT during this relatively short period of time.
Finally, some of the limitations of the present survey need to be remarked upon: the delegates who attended this meeting were obviously a self-selected population group and their answers cannot reasonably reflect the worldwide daily reality of patient care, because there is clearly a European bias in our results. As a matter of fact, the answers of the participants do not necessarily completely reflect the actual clinical practice worldwide and they might represent a sample of 'expert operators' in the field of RRT. Moreover, these results should be viewed as a collection of opinions and thoughts rather than an accurate description of clinical practice. Also, one must take into account that, even if we explicitly asked responders to provide their personal opinions, they have been trained during the course and their views might have been modified. Finally, in a relatively small (but also unquantifiable) number of cases, participants might have simply been providing answers as though they were completing a (right or wrong) test instead of communicating their personal experience. Nevertheless, it must be said that participants were invited to fill in the questionnaire on a voluntary basis, and they were explicitly asked to frankly and freely state their personal opinions. Furthermore, this is the third time we have submitted this questionnaire in the last 12 years: the analyzed answers show coherent and clear trends towards a homogeneous modification of the opinions of those who participated, and these responses reliably reflect some of the changes that have taken place in real-world clinical practice.
Conclusion
Our results must be seen in the light of a self-selected, European-biased survey. Nevertheless, we considered it a unique opportunity to interview a large number of specialized operators in the field of critical care nephrology. Our survey confirmed an evident trend towards a standardization of the AKI definition: the RI-FLE criteria seem to be showing a clinical impact on daily practice. A trend towards increased awareness about RRT dosage seems evident when compared with previous surveys, even if there are still no definitive indications for RRT and no guidelines about prescribing RRT among practitioners in the field of critical care nephrology.
